These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 22208729)

  • 1. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
    de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
    J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P450(BM3) on steroids: the Swiss Army knife P450 enzyme just gets better.
    Wong LL
    Chembiochem; 2011 Nov; 12(17):2537-9. PubMed ID: 21998091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
    Huang WC; Cullis PM; Raven EL; Roberts GC
    Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.
    Venkataraman H; Beer SB; Bergen LA; Essen Nv; Geerke DP; Vermeulen NP; Commandeur JN
    Chembiochem; 2012 Mar; 13(4):520-3. PubMed ID: 22275147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
    Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
    J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
    Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
    Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
    Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
    Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
    Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
    ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
    Cha GS; Ryu SH; Ahn T; Yun CH
    Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
    Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
    Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.
    de Beer SB; van Bergen LA; Keijzer K; Rea V; Venkataraman H; Guerra CF; Bickelhaupt FM; Vermeulen NP; Commandeur JN; Geerke DP
    Curr Drug Metab; 2012 Feb; 13(2):155-66. PubMed ID: 22208530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering cytochrome P450 BM3 of Bacillus megaterium for terminal oxidation of palmitic acid.
    Brühlmann F; Fourage L; Ullmann C; Haefliger OP; Jeckelmann N; Dubois C; Wahler D
    J Biotechnol; 2014 Aug; 184():17-26. PubMed ID: 24833423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
    Neeli R; Roitel O; Scrutton NS; Munro AW
    J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.